TITLE

Monetising a platform technology

AUTHOR(S)
Ogru, Esra
PUB. DATE
October 2011
SOURCE
Australasian Biotechnology;Oct2011, Vol. 21 Issue 3, p30
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This sector is acutely aware of the squeeze on Australian companies in raising ongoing capital. Phosphagenics is implementing a range of strategies to reduce the need to return to the market for capital. Phosphagenics' primary goal is to develop a transdermal oxycodone patch. A successfully commercialised product would tap into the $6 billion per annum market for chronic pain treatments. The oxycodone market alone is $3.2 billion per annum. Over the last few years Phosphagenics has implemented an innovative revenue creation strategy.
ACCESSION #
66623697

 

Related Articles

  • POSITIVE RESULTS FROM PHASE 1B OF OXYCODONE PATCH.  // Worldwide Biotech;Mar2010, Vol. 22 Issue 3, p1 

    The article reports on the positive results of the Phase 1B clinical study conducted by Phosphagenics Ltd. using its Targeted Penetration Matrix (TPMâ„¢) for the transdermal delivery of oxycodone. The trial has successfully demonstrated that daily application of a TPMâ„¢-oxycodone patch...

  • Phosphagenics working on topical opioid patch.  // Australian Life Scientist;Mar/Apr2013, Vol. 10 Issue 2, p6 

    The article informs that Phosphagenics Ltd. has included an oxycodone-based patch designed for local pain relief in its pain patch portfolio and is also planning to start clinical trials of a similar version of the patch in the third quarter.

  • R&D Update.  // PharmaWatch: CNS;Nov2007, Vol. 6 Issue 11, p10 

    The article offers news briefs related to pharmaceutical industry worldwide in 2007. Adlea is a long-acting, non-opiate analgesic drug which designed for weeks to months pain relief in single local dose during the surgical procedure. Australian company Phosphagenics has received approval to...

  • Transdermal Buprenorphine. Likar, Rudolf // Drugs;2003, Vol. 63 Issue 19, p2011 

    Reports on the use of a transdermal therapeutic system containing buprenorphine to manage pain. Avoidance of gastrointestinal passage and first-pass metabolism; Continuous slow release of buprenorphine at a defined rate from its polymer matrix into the blood; Efficacy and safety of transdermal...

  • Use of Transdermal Fentanyl in Patients with Continuous Non-Malignant Pain: A Case Report Series. Libretto, S.E. // Clinical Drug Investigation;2002, Vol. 22 Issue 7, p473 

    Objective: The aim of this case report series is to detail the use in a clinical setting of transdermal fentanyl patches for the treatment of patients with continuous non-malignant pain. Case reports: These cases, collected in Ireland, describe patients with back pain, leg pain, arthritic pain...

  • Transdermal Fentanyl for Postoperative Pain Management. Caplan, Robert A.; Ready, L. Brian; Oden, Rollin V.; Matsen III, Frederick A.; Nessly, Michael L.; Olsson, Gayle L. // JAMA: Journal of the American Medical Association;2/17/89, Vol. 261 Issue 7, p1036 

    Evaluates the safety and efficacy of transdermal fentanyl citrate for post-operative pain management in patients undergoing shoulder injury. Effects on the incidence of vomiting and respiratory rate; Percentage of patients exhibiting episodes of narcotic-related side effects during application...

  • When Your Pain Patient Has Trouble Falling Asleep. Scholz, Mary J. // RN;May2002, Vol. 65 Issue 5, p98 

    Presents a question and answer advisory on pain management. Effects of oxycodone on the sleeping process of patients; Use of a sedative-hypnotic medicine to help patients with chronic back pain to sleep; Risk associated with zolpidem.

  • Comparison of oxycodone and sufentanil for patient-controlled intravenous analgesia after laparoscopic radical gastrectomy: A randomized double-blind clinical trial. Na Wang; Xuesong Song; Honglan Zhou; Jinguo Wang // Anesthesia: Essays & Researches;Sep-Dec2016, Vol. 10 Issue 3, p557 

    Background: Sufentanil is widely used for patient-controlled intravenous analgesia (PCIA). Oxycodone has a powerful analgesic effect and mild side effects. We conducted this study to compare the efficacy of oxycodone and sufentanil for PCIA on postoperative pain after laparoscopic radical...

  • Home based application of transdermal cryoanalgesia as interventional pain management among Nigerian physiotherapists. Teslim, Onigbinde Ayodele; Talabi, A. E.; Olaoye, O.; Oniyangi, S.; Olaitan, O. L.; Odeyemi, E. // Sports Medicine Journal / Medicina Sportivâ;2012, Vol. 8 Issue 1, p1775 

    Aim and scope: The primary purpose of this study was to sample the opinion of physiotherapists on the prescription of cryoanalgesia for patients' home based use in Nigeria. Material and methods: A total of 152 physiotherapists (PTs) were selected from hospitals in south-west Nigeria. The...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics